Belinostat is a histone deacetylase inhibitor used to treat peripheral T-cell lymphoma. It works by inducing cell cycle arrest and apoptosis in cancer cells. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Beleodaq and N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide. Its PubChem CID is 6918638.
Belinostat
| CAS No | 866323-14-0 |
|---|---|
| Molecular Formula | C15H14N2O4S |
| Molecular Weight | 318.3 g/mol |
| Synonyms | (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Belinostat is a histone deacetylase inhibitor used to treat peripheral T-cell lymphoma. It works by inducing cell cycle arrest and apoptosis in cancer cells. Its therapeutic use is listed as anti-cancer agents.
The listed CAS number is 866323-14-0.
The listed molecular formula is C15H14N2O4S.
The listed molecular weight is 318.3 g/mol.
(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide.
The source lists Beleodaq and N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide.